The SGLT2 inhibitor Empagliflozin promotes post-stroke functional recovery in diabetic mice
Article in Cardiovascular Diabetology (February 2024)
The most recent citing publications are shown below. View all 30 publications that cite this research output on Dimensions.
Article in Cardiovascular Diabetology (February 2024)
Article in Prospects in Pharmaceutical Sciences (February 2024)
Article in International Journal of Molecular Sciences (February 2024)